Thomas Volken
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Koster K, Messerich N, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W, Rao T, Silzle T. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers (Basel) 2023; 15
24.09.2023Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
24.09.2023Cancers (Basel) 2023; 15
Koster Kira-Lee, Messerich Nora-Medea, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Graf Lukas, Holbro Andreas, Benz Rudolf, Demmer Izadora, Jochum Wolfram, Rao Tata Nageswara, Silzle Tobias
Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
Sutter T, Schittenhelm M, Volken T, Lehmann T. Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis. Hematology 2023; 28:2206694.
11.05.2023Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
11.05.2023Hematology 2023; 28:2206694
Sutter Tabea, Schittenhelm Marcus, Volken Thomas, Lehmann Thomas
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
Tancredi S, Ulyte A, Wagner C, Keidel D, Witzig M, Imboden M, Probst-Hensch N, Amati R, Albanese E, Levati S, Crivelli L, Kohler P, Cusini A, Kahlert C, Harju E, Michel G, Luedi C, Ortega N, Baggio S, Chocano-Bedoya P, Rodondi N, Ballouz T, Frei A, Kaufmann M, von Wyl V, Lorthe E, Baysson H, Stringhini S, Schneider V, Kaufmann L, Wieber F, Volken T, Zysset A, Dratva J, Cullati S, Corona Immunitas Research Group. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland. Int J Equity Health 2023; 22:51.
23.03.2023Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
23.03.2023Int J Equity Health 2023; 22:51
Tancredi Stefano, Ulyte Agne, Wagner Cornelia, Keidel Dirk, Witzig Melissa, Imboden Medea, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Levati Sara, Crivelli Luca, Kohler Philipp, Cusini Alexia, Kahlert Christian, Harju Erika, Michel Gisela, Luedi Chantal, Ortega Natalia, Baggio Stéphanie, Chocano-Bedoya Patricia O, Rodondi Nicolas, Ballouz Tala, Frei Anja, Kaufmann Marco, von Wyl Viktor, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Schneider Valentine, Kaufmann Laurent, Wieber Frank, Volken Thomas, Zysset Annina, Dratva Julia, Cullati Stéphane, Corona Immunitas Research Group
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Messerich N, Uda N, Volken T, Cogliatti S, Lehmann T, Holbro A, Benz R, Graf L, Gupta V, Jochum W, Demmer I, Rao T, Silzle T. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers (Basel) 2023; 15
25.02.2023CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
25.02.2023Cancers (Basel) 2023; 15
Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobias